Reneuron Share Discussion Threads

[bonzo] 26/4/2019 07:14

A a developer of new drugs, I know that the most exciting thing is to know that millions of patients have better lives. I have contributed to antivirals, retrovirals, epilepsy and malaria treatments. It's a great feeling.

[someuwin] 26/4/2019 07:10

Awesome!

Pravin Dugel MD, Managing Partner, Retinal Consultants of Arizona, Phoenix, Arizona, and Clinical Professor, Roski Eye Institute, USC Keck School of Medicine, Los Angeles, California, and study investigator, commented:

"I am excited that the rapid and remarkable visual improvement in these RP patients has been sustained and even improved upon at 60 and 120 days. It is especially gratifying to feel the excitement and joy in my patients where this objective and subjective improvement in their vision has been a source of hope following years of slow but steady progression towards blindness."

[bonzo] 26/4/2019 07:07

Announcement could not be more positive than that!!

[lauders] 26/4/2019 01:59

So, today is the day that we (especially patients who could be helped) hear more news from RENE. Looking forward to any feedback from the last presentation of note mentioned in this piece:

Presentations of Note

FRIDAY, APRIL 26

•12:15 PM – 12:30 PM: Ascl1-mediated reprogramming of Müller glia promotes functional regeneration in mouse retina Dr. Thomas Reh, University of WashingtonIn this exciting presentation, Dr. Reh will share information on promising new research to enable targeted cell regeneration, allowing the eye to produce new, functional photoreceptors.

•1:20 PM – 1:45 PM: [KEYNOTE] Gene Therapy for Retinal Disease Dr. Robert MacLaren, University of OxfordIn our keynote speech, Dr. MacLaren will share insights from his work as lead investigator for choroideremia, cross-linked retinopathy of prematurity, and dry AMD gene therapy clinical trials.

•1:45 PM – 2:00 PM: Subretinal implantation of human retinal progenitor stem cells Dr. Jason Comander, Massachusetts Eye and EarHere, Dr. Comander will review early, encouraging vision improvements for the ReNeuron Phase 2 retinal progenitor clinical trial for patients with retinopathy of prematurity.

[yachtmaster2] 25/4/2019 18:57

I sincerely hope so this time Rayac!

[rayrac] 25/4/2019 17:31

Great to be a part of it. Could be an awesome ride!

[eggy6198] 25/4/2019 17:07

Well it had to pop 50/50 on news tomorrow be great to watch conference bit silly if they dont pop share price into conference with RNS at 7am

[masingi] 25/4/2019 09:23

I hope it continues until NASDAQ opens, I can flip some shares and buy some more.

[eggy6198] 25/4/2019 09:15

And also always a drop after the hold. Basically will drive the little fish away which is what the whole system relies on. What sort of investor is selling now two days before huge news just after a load of director buying on seriously undervalued stock? This is start looking like it might just double on a tuesday morning for no reason as looks held back. 5 to 10% spread and walk downs. Signs are there

[masingi] 25/4/2019 09:11

Thanks. Interesting.

A couple of large buys seem to have just gone through at a lower than expected price.

[eggy6198] 25/4/2019 09:11

Its simple to make money. Natural laws of investing are dead in super corrupt market place, week regulstors and AI.

[small crow] 25/4/2019 09:01

They are Direct Access customers, they use very sophisticated algorithms and they do it to accumulate more at a low price. Probably, since we will never know the truth.

[masingi] 25/4/2019 08:36

Eggy,
How do 'they' hold it? How is it done, and to what purpose?

Thanks.

[eggy6198] 25/4/2019 08:31

Being held

[bg23] 25/4/2019 08:29

PDT & small crow. thanks for coming back on my query.
as I said above, I am not a scientist by any measure, but I feel like I want to better understand this new area. it seems fascinating.

now, where are my reading glasses...... :-)


Regards

[someuwin] 25/4/2019 08:17

Lots of buying already.

[small crow] 25/4/2019 07:29

Apple rose from a low of (from memory) $11 per share.

[bantam175] 25/4/2019 07:24

imo the only thing holding this back is the share consolidation. If we were still trading at 1-2p it would be easy to jump up to 5 or 6 as has happened in the past. The higher the share price the more difficult it is to jump up.
A form of financial gravity I suppose ;-))

All imo dyor etc.

[small crow] 24/4/2019 21:26

bg23

I'm a biologist but not a specialist in this field. However, what might happen with a re-activation of retinal cells is that the connections between those and the optic tectum (at the back of the head), which may have lost some function during the inactivity of retinal cells, may regain function and start to "recalibrate" in the light of their new sensory input. Analagous to what happens in mammals after birth when they "learn" to see. Wouldn't surprise me at all.

[eggy6198] 24/4/2019 19:35

Basically great answer already. I am looking at mkt value and ignoring the other products. If the chinnese are willing to sign a deal worth more than the mkcap says it all. If this product works in 3 to 5 years the company will sell for billions literally. Even if its still a 30% shot it shoyld be 300m mkcap at this point. Read the press!

[someuwin] 24/4/2019 18:52

Those broker numbers (625p, 630p & 900p) are not future targets, but their calculated CURRENT valuations of RENE.

As RENE makes further progress with their trials these valuations will increase further still.

Proven success and this will be trading in the billions.

As Edison point out, even now RENE is valued significantly below its closest public comparator, SanBio, which is listed in Japan and has a c £3bn market capitalisation.

[sharestobuy] 24/4/2019 18:28

Eggy6198, based on current market cap what is the true valued share price of RENE?

Im still learning but i do know P/E ratio is a good way to evaluate a stock

[eggy6198] 24/4/2019 18:14

Its not going to crash if results are good look at mkcap and then value... its silly already